Malignant Cardiovascular Neoplasm — Trials

Malignant Cardiovascular Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

196 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 37
Recruiting: 23
Ph III recruiting: 0
Growth YoY: —
Industry share: 14%
Top sponsor: National Cancer Institute (NCI)
Termination share: 32.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (21)

clinicaltrialsPublishedShowing 51–53 of 53 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06526897	Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma	not yet recruiting	N/A	1,582	ECOG-ACRIN Cancer Research GroupNETWORK	0	Jul 30, 2024	clinicaltrials
NCT05961761	Propranolol and Pembrolizumab in Advanced Soft Tissue Sarcoma Patients(PROPANE)	recruiting	Phase 2	80	Niels JunkerOTHER	3	Jul 27, 2023